Emma Pascal Danhash

Emma Pascal Danhash

Auto-generated profile, based on publicly available information

Emma Pascal Danhash

Department of Psychiatry, Washington University in St. Louis School of Medicine

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2022 in Cell Reports
Verified
Journal Article
Open access
SSSepideh Kiani Shabestari
Sepideh Kiani Shabestari
SMSamuel Morabito
Samuel Morabito
EDEmma Pascal Danhash
Emma Pascal Danhash
AMAmanda McQuade
Amanda McQuade
JSJessica Ramirez Sanchez
Jessica Ramirez Sanchez
MBMathew Blurton-Jones
Mathew Blurton-Jones
Microglia are strongly implicated in the development and progression of Alzheimer’s disease (AD), yet their impact on pathology and lifespan remains unclear. Here we utilize a CSF1R hypomorphic mouse to generate a model of AD that genetically lacks microglia. The resulting microglial-deficient mice exhibit a profound shift from parenchymal amyloid plaques to cerebral amyloid angiopathy (CAA), which is accompanied by numerous transcriptional changes, greatly increased brain calcification and hemorrhages, and premature lethality. Remarkably, a single injection of wild-type microglia into adult mice repopulates the microglial niche and prevents each of these pathological changes. Taken together, these results indicate the protective functions of microglia in reducing CAA, blood-brain barrier dysfunction, and brain calcification. To further understand the clinical implications of these findings, human AD tissue and iPSC-microglia were examined, providing evidence that microglia phagocytose calcium crystals, and this process is impaired by loss of the AD risk gene, TREM2.

1 December 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
JPJohn V. Pluvinage
John V. Pluvinage
JSJerry Sun
Jerry Sun
CCChristel Claes
Christel Claes
RFRyan A. Flynn
Ryan A. Flynn
MHMichael S. Haney
Michael S. Haney
TWTony Wyss-Coray
Tony Wyss-Coray
An oligodendrocyte-derived protein in cerebrospinal fluid impairs microglial lysosome function.

27 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
EDEmma P. Danhash
Emma P. Danhash
SFShao-Yu Fang
Shao-Yu Fang
JMJacob A. Marsh
Jacob A. Marsh
RARicardo D’Oliveira Albanus
Ricardo D’Oliveira Albanus
AVAnthony C. Verbeck
Anthony C. Verbeck
CKCeleste M. Karch
Celeste M. Karch
INTRODUCTION: Microglia regulate amyloid plaque-associated microenvironments that contribute to downstream tau pathology in Alzheimer’s disease (AD). Variants within the MS4A locus are strongly associated with AD risk and resilience and are linked to microglial biology; however, the functional role of MS4A4A in plaque-associated tau pathology remains poorly understood. METHODS: Single-nucleus RNA sequencing (snRNA-seq) was performed on hippocampi from non-transgenic, Ms4a4a knockout (4A-KO), 5xFAD, and 5xFAD 4A-KO mice at 6 months of age. To assess plaque-associated tau pathology, AD-derived tau aggregates were injected into the hippocampus of 5xFAD and 5xFAD 4A-KO mice at 6 months, and histological analyses were performed 3 months later. RESULTS: Amyloid pathology was the dominant driver of microglial state transitions, while Ms4a4a loss selectively remodeled activated microglial transcriptional programs enriched for interferon, lysosomal, autophagic, and proteostatic pathways. Activated microglia from 5xFAD 4A-KO mice exhibited altered expression of genes linked to immune signaling and protein handling. Following AD-tau inoculation, Ms4a4a loss did not significantly alter overall phospho-tau burden but selectively reduced dense-core plaque-associated neuritic plaque tau (NP-tau), particularly in the contralateral hemisphere. This phenotype was strongest surrounding X-34-positive fibrillar plaques and occurred without major changes in plaque-associated microgliosis. DISCUSSION: These findings identify Ms4a4a as a regulator of plaque-associated microglial programs linked to NP-tau accumulation in the amyloid-bearing brain. More broadly, this work supports a model in which AD resilience-associated microglial pathways selectively shape plaque-associated microenvironments that promote downstream tau pathology.